For example, the CSC surface markers CD44+ and CD24− were defined in breast cancer, CD20+ and ABCB5+ in melanoma, and EpCAM+, CD44+, and CD166+ in colon cancer [49]. This evidence concerns the gene ALCAM and breast cancer.